Skip to main content

Halozyme Therapeutics, Inc.

HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001159036

In the last 90 days, Halozyme Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 674 institutions reported holding it in 13F filings for Q2 2026, worth $9.62B in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Halozyme Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
411
+27 vs. Q3 2023
Shares held
124.7M
+1.68M (+1.4%) vs. Q3 2023
Total value
$4.62B
−$86.1M (−1.8%) vs. Q3 2023
New holders
63
146 more added
Sold out
36
146 more reduced

6 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HALO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 411 institutions
Q1 2021: 337 institutionsQ2 2021: 315 institutionsQ3 2021: 326 institutionsQ4 2021: 326 institutionsQ1 2022: 316 institutionsQ2 2022: 368 institutionsQ3 2022: 357 institutionsQ4 2022: 423 institutionsQ1 2023: 387 institutionsQ2 2023: 370 institutionsQ3 2023: 390 institutionsQ4 2023: 411 institutionsQ1 2024: 413 institutionsQ2 2024: 460 institutionsQ3 2024: 510 institutionsQ4 2024: 509 institutionsQ1 2025: 550 institutionsQ2 2025: 552 institutionsQ3 2025: 604 institutionsQ4 2025: 619 institutionsQ1 2026: 637 institutionsQ2 2026: 674 institutions
Value heldQ4 2023: $4.62B
Q1 2021: $5.53BQ2 2021: $5.89BQ3 2021: $5.29BQ4 2021: $5.21BQ1 2022: $5.12BQ2 2022: $5.65BQ3 2022: $5.21BQ4 2022: $7.35BQ1 2023: $4.77BQ2 2023: $4.45BQ3 2023: $4.71BQ4 2023: $4.62BQ1 2024: $5.03BQ2 2024: $6.40BQ3 2024: $7.17BQ4 2024: $5.86BQ1 2025: $7.72BQ2 2025: $6.05BQ3 2025: $8.75BQ4 2025: $8.29BQ1 2026: $7.79BQ2 2026: $9.62B
Institutions holding HALO and their total value by quarter
QuarterHoldersValue
Q2 2026674$9.62B
Q1 2026637$7.79B
Q4 2025619$8.29B
Q3 2025604$8.75B
Q2 2025552$6.05B
Q1 2025550$7.72B
Q4 2024509$5.86B
Q3 2024510$7.17B
Q2 2024460$6.40B
Q1 2024413$5.03B
Q4 2023411$4.62B
Q3 2023390$4.71B
Q2 2023370$4.45B
Q1 2023387$4.77B
Q4 2022423$7.35B
Q3 2022357$5.21B
Q2 2022368$5.65B
Q1 2022316$5.12B
Q4 2021326$5.21B
Q3 2021326$5.29B
Q2 2021315$5.89B
Q1 2021337$5.53B

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Halozyme Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding HALO in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Invesco Ltd.2,030,634$75.1M0.02%+13,612+0.7%Added
GW&K Investment Management, LLC2,226,538$82.3M0.77%−117,767−5.0%Reduced
Geode Capital Management, LLC2,919,763$107.9M0.01%+132,414+4.8%Added
JPMorgan Chase & Co3,093,932$114.4M0.01%−69,333−2.2%Reduced
Macquarie Group Ltd3,282,640$121.3M0.14%−161,550−4.7%Reduced
Alliancebernstein L.P.3,463,694$128.0M0.05%+106,918+3.2%Added
Snyder Capital Management L P3,709,599$142.9M3.22%−614,633−14.2%Reduced
State Street Corp6,475,549$239.3M0.01%+266,018+4.3%Added
Artisan Partners Limited Partnership6,689,058$247.2M0.39%−1,023,816−13.3%Reduced
Vanguard Group Inc13,259,514$490.1M0.01%+152,870+1.2%Added
BlackRock Inc.18,630,963$688.6M0.02%+512,348+2.8%Added
Adage Capital Partners GP, L.L.C.0$00.00%−400,000−100.0%Sold out
Arrowstreet Capital, Limited Partnership0$00.00%−101,211−100.0%Sold out
Squarepoint Ops LLC0$00.00%−77,945−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−52,558−100.0%Sold out
FIL Ltd0$00.00%−39,161−100.0%Sold out
Weiss Multi-Strategy Advisers LLC0$00.00%−38,259−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−32,160−100.0%Sold out
Axiom Investors LLC0$00.00%−31,715−100.0%Sold out
XTX Topco Ltd0$00.00%−28,504−100.0%Sold out
Boussard & Gavaudan Investment Management LLP0$00.00%−21,964−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−17,510−100.0%Sold out
Chartwell Investment Partners, LLC0$00.00%−13,649−100.0%Sold out
One Capital Management, LLC0$00.00%−10,075−100.0%Sold out
Wealth Enhancement Advisory Services, LLC0$00.00%−9,606−100.0%Sold out
Group One Trading, L.P.0$00.00%−9,213−100.0%Sold out
Clough Capital Partners L P0$00.00%−9,000−100.0%Sold out
United Capital Financial Advisers, LLC0$00.00%−7,516−100.0%Sold out
Dana Investment Advisors, Inc.0$00.00%−6,513−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−6,512−100.0%Sold out
Bridgefront Capital, LLC0$00.00%−6,238−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−6,167−100.0%Sold out
Tocqueville Asset Management L.P.0$00.00%−5,900−100.0%Sold out
Wolverine Trading, LLC0$00.00%−5,691−100.0%Sold out
Lloyd Advisory Services, LLC.0$00.00%−5,635−100.0%Sold out
Portside Wealth Group, LLC0$00.00%−5,601−100.0%Sold out
Simplex Trading, LLC0$00.00%−5,485−100.0%Sold out
TCTC Holdings, LLC0$00.00%−2,813−100.0%Sold out
Twin Tree Management, LP0$00.00%−1,550−100.0%Sold out
USA Financial Portformulas Corp0$00.00%−1,226−100.0%Sold out
NVWM, LLC0$00.00%−302−100.0%Sold out
Trust Co of Vermont0$00.00%−200−100.0%Sold out
Front Row Advisors LLC0$00.00%−134−100.0%Sold out
Milestone Investment Advisors LLC0$00.00%−45−100.0%Sold out
Nemes Rush Group LLC0$00.00%−20−100.0%Sold out
Prestige Wealth Management Group LLC0$00.00%−8−100.0%Sold out
Baker Avenue Asset Management, LP0$00.00%−7−100.0%Sold out
Colony Group LLC––––Not filed
International Biotechnology Trust PLC––––Not filed
Virginia Retirement Systems Et Al––––Not filed
First Republic Investment Management, Inc.––––Not filed
Pathstone Family Office, LLC––––Not filed
Steward Financial Group LLC––––Not filed